Loading company…
Shanghai-based preclinical research company offering pharmacology, toxicology and medical device evaluation services.
Based in Shanghai and established in 2008, PharmaLegacy provides preclinical biomedical research and development services, including pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology and medical device evaluation. Its 10000 square meter laboratory includes a 4000 square meter animal vivarium accredited by AAALAC. In February 2025, Shanghai OPM Biosciences announced it would fully acquire PharmaLegacy.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in